Samuel George A. III
SEC CIK 1878732 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics, Inc. | GC, Sec | 33.6K | $9,000 | — | 11 | 2023-02-11 | 2026-02-11 |
Most active insiders at LCTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Culley Brian M | Pres, CEO, Dir | $24.4K | — |
| 2 | Samuel George A. III | GC, Sec | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-13 | 2026-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | GC, Sec | M - OptEx | — | +6,075 | 33.6K | +22% | — |
| D | 2026-02-13 | 2026-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | GC, Sec | F - Tax | $1.80 | -2,502 | 31.1K | -7% | -$4,504 |
| 2025-12-19 | 2025-12-19 | LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | GC, Sec | A - Grant | — | +1,735 | 27.6K | +7% | — | |
| 2025-12-19 | 2025-12-19 | LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | GC, Sec | F - Tax | $1.68 | -65 | 27.5K | -0.2% | -$109.20 | |
| D | 2025-02-12 | 2025-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | GC | M - OptEx | — | +6,076 | 28.3K | +27% | — |
| D | 2025-02-12 | 2025-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | GC | F - Tax | $0.65 | -2,440 | 25.8K | -9% | -$1,586 |
| 2024-11-26 | 2024-11-26 | LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | GC | P - Purchase | $0.6 | +15.0K | 22.2K | +209% | +$9,000 | |
| D | 2024-02-12 | 2024-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | GC, Sec | M - OptEx | — | +6,076 | 9,674 | +169% | — |
| D | 2024-02-12 | 2024-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | GC, Sec | F - Tax | $1.08 | -2,490 | 7,184 | -26% | -$2,689 |
| D | 2023-02-14 | 2023-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | GC, Sec | M - OptEx | — | +6,076 | 6,076 | New | — |
| D | 2023-02-14 | 2023-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | GC, Sec | F - Tax | $1.35 | -2,478 | 3,598 | -41% | -$3,345 |
Purchase Sale Sale after option exercise All abbreviations